Boston Scientific Corpora... (BSX)

NYSE: BSX · Real-Time Price · USD

105.22

2.03 (1.97%)

At close: May 02, 2025, 3:36 PM

Boston Scientific Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Cash & Equivalents	414M	865M	928M	1.93B	1.73B	217M	146M	188M	196M
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	555M	413M	407M	412M	918M	458M	-328M	-191M	-75M
Other Long-Term Assets	1.3B	680M	707M	563M	545M	735M	932M	688M	666M
Receivables	2.56B	2.23B	1.97B	1.78B	1.53B	1.83B	1.61B	1.55B	1.47B
Inventory	2.81B	2.48B	1.87B	1.61B	1.35B	1.58B	1.17B	1.08B	955M
Other Current Assets	831M	622M	731M	799M	1.88B	880M	922M	942M	541M
Total Current Assets	6.92B	6.51B	5.76B	6.32B	6.69B	4.7B	4B	3.82B	3.24B
Property-Plant & Equipment	3.74B	3.3B	2.83B	2.69B	2.54B	2.42B	1.78B	1.7B	1.63B
Goodwill & Intangibles	23.77B	20.39B	18.82B	18.11B	15.87B	18.06B	14.28B	12.84B	12.56B
Total Long-Term Assets	32.48B	28.62B	26.71B	25.91B	24.08B	25.87B	17B	15.22B	14.86B
Total Assets	39.4B	35.14B	32.47B	32.23B	30.78B	30.57B	21B	19.04B	18.1B
Account Payables	960M	942M	862M	794M	513M	542M	349M	530M	447M
Deferred Revenue	n/a	266M	220M	208M	138M	144M	328M	191M	75M
Short-Term Debt	1.78B	531M	20M	261M	13M	1.42B	2.25B	1.8B	64M
Other Current Liabilities	3.39B	1.92B	1.64B	629M	1.17B	861M	2.03B	2.73B	2.5B
Total Current Liabilities	6.4B	4.93B	3.8B	4.27B	3.68B	4.87B	5.26B	5.65B	3.59B
Long-Term Debt	8.84B	8.57B	8.91B	8.8B	9.12B	8.59B	4.8B	3.81B	5.42B
Other Long-Term Liabilities	2B	1.27B	1.4B	1.55B	1.66B	2.36B	1.88B	2.37B	2.34B
Total Long-Term Liabilities	10.99B	10.67B	11.09B	11.33B	11.77B	11.82B	7.01B	6.38B	7.78B
Total Liabilities	17.39B	15.61B	14.9B	15.61B	15.45B	16.69B	12.27B	12.03B	11.36B
Total Debt	11.15B	9.49B	9.28B	9.45B	9.54B	10.28B	7.03B	5.58B	5.48B
Common Stock	17M	17M	17M	17M	17M	16M	16M	16M	19M
Retained Earnings	2.67B	819M	-750M	-1.39B	-2.38B	-2.25B	-6.95B	-8.39B	-8.58B
Comprehensive Income	275M	49M	269M	263M	207M	270M	33M	-59M	1M
Shareholders Equity	21.77B	19.28B	17.57B	16.62B	15.33B	13.88B	8.72B	7.01B	6.73B
Total Investments	555M	413M	407M	412M	918M	458M	-328M	-191M	-75M